Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 12 March, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo

Coromandel International Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 9, 2025, 8:07 pm

Market Cap 51,744 Cr.
Current Price 1,756
High / Low 1,978/1,037
Stock P/E31.6
Book Value 345
Dividend Yield0.34 %
ROCE26.0 %
ROE18.9 %
Face Value 1.00
PEG Ratio7.34

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Coromandel International Ltd

Competitors of Coromandel International Ltd

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Gujarat State Fertilizers & Chemicals Ltd 6,865 Cr. 172 275/15812.6 3372.33 %5.77 %4.55 % 2.00
Bharat Agri Fert & Realty Ltd 211 Cr. 40.0 118/39.5 9.970.12 %6.14 %14.8 % 1.00
Basant Agro Tech (India) Ltd 119 Cr. 13.1 24.9/12.112.2 19.50.38 %5.65 %1.30 % 1.00
Zuari Agro Chemicals Ltd 811 Cr. 193 268/1513.68 4220.00 %8.50 %3.44 % 10.0
Southern Petrochemicals Industries Corporation Ltd (SPIC) 1,665 Cr. 81.7 96.7/64.410.4 56.41.84 %17.8 %14.4 % 10.0
Industry Average8,884.86 Cr317.9541.80165.700.72%21.99%10.62%7.35

All Competitor Stocks of Coromandel International Ltd

Quarterly Result

MetricDec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Sales 5,0734,2275,72910,1138,3105,4765,6936,9885,4643,9134,7297,4336,935
Expenses 4,5293,8485,0449,0567,5395,0894,9885,9335,1153,6504,2386,4716,222
Operating Profit 5443796851,0577713877061,055349263490962713
OPM % 11%9%12%10%9%7%12%15%6%7%10%13%10%
Other Income 287755324047444559845465114
Interest 18212754575241463862576673
Depreciation 43454546474548546463656971
Profit before tax 5113896699897063376611,000306222422892683
Tax % 25%26%25%25%25%27%25%25%25%26%27%26%26%
Net Profit 382290499741527246494755228164309659508
EPS in Rs 13.009.8716.9925.2017.928.3816.8025.717.855.4510.5622.5517.37

Last Updated: March 3, 2025, 4:55 pm

Below is a detailed analysis of the quarterly data for Coromandel International Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

  • For Sales, as of Dec 2024, the value is ₹6,935.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7,433.00 Cr. (Sep 2024) to ₹6,935.00 Cr., marking a decrease of 498.00 Cr..
  • For Expenses, as of Dec 2024, the value is ₹6,222.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 6,471.00 Cr. (Sep 2024) to ₹6,222.00 Cr., marking a decrease of 249.00 Cr..
  • For Operating Profit, as of Dec 2024, the value is ₹713.00 Cr.. The value appears to be declining and may need further review. It has decreased from 962.00 Cr. (Sep 2024) to ₹713.00 Cr., marking a decrease of 249.00 Cr..
  • For OPM %, as of Dec 2024, the value is 10.00%. The value appears to be declining and may need further review. It has decreased from 13.00% (Sep 2024) to 10.00%, marking a decrease of 3.00%.
  • For Other Income, as of Dec 2024, the value is ₹114.00 Cr.. The value appears strong and on an upward trend. It has increased from 65.00 Cr. (Sep 2024) to ₹114.00 Cr., marking an increase of ₹49.00 Cr..
  • For Interest, as of Dec 2024, the value is ₹73.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 66.00 Cr. (Sep 2024) to ₹73.00 Cr., marking an increase of ₹7.00 Cr..
  • For Depreciation, as of Dec 2024, the value is ₹71.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 69.00 Cr. (Sep 2024) to ₹71.00 Cr., marking an increase of ₹2.00 Cr..
  • For Profit before tax, as of Dec 2024, the value is ₹683.00 Cr.. The value appears to be declining and may need further review. It has decreased from 892.00 Cr. (Sep 2024) to ₹683.00 Cr., marking a decrease of 209.00 Cr..
  • For Tax %, as of Dec 2024, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 26.00%.
  • For Net Profit, as of Dec 2024, the value is ₹508.00 Cr.. The value appears to be declining and may need further review. It has decreased from 659.00 Cr. (Sep 2024) to ₹508.00 Cr., marking a decrease of 151.00 Cr..
  • For EPS in Rs, as of Dec 2024, the value is 17.37. The value appears to be declining and may need further review. It has decreased from ₹22.55 (Sep 2024) to 17.37, marking a decrease of ₹5.18.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 4:32 pm

MetricMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales 9,03410,05311,30611,48110,03111,08313,22513,13714,18219,11129,62822,05823,010
Expenses 8,2649,24610,45010,7129,0489,82211,77511,40012,19316,95426,72619,67820,581
Operating Profit 7708088567699831,2611,4501,7371,9892,1562,9022,3802,428
OPM % 9%8%8%7%10%11%11%13%14%11%10%11%11%
Other Income 68465087545583576141171223316
Interest 21024021022122417825123510675190187258
Depreciation 719610510610199114158173173182229268
Profit before tax 5575175925297121,0381,0931,3791,7862,0502,7012,1882,218
Tax % 22%29%32%32%33%33%34%23%26%25%25%25%
Net Profit 4343654023574776917201,0651,3291,5282,0131,6411,640
EPS in Rs 15.2612.5913.8012.2716.3523.6424.6336.3645.3052.0868.4655.7855.93
Dividend Payout % 29%36%33%33%31%27%26%33%26%23%18%11%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)-15.90%10.14%-11.19%33.61%44.86%4.20%47.92%24.79%14.97%31.74%-18.48%
Change in YoY Net Profit Growth (%)0.00%26.04%-21.33%44.81%11.25%-40.67%43.72%-23.13%-9.82%16.77%-50.22%

Coromandel International Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

No data available for the compounded sales growth chart.

Balance Sheet

Last Updated: November 15, 2024, 1:29 am

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital 28282929292929292929292929
Reserves 2,1682,2532,1732,6052,8622,8673,3294,2885,1216,3297,8789,39010,126
Borrowings 2,9461,8432,2882,6772,2282,7282,9542,019385395393492580
Other Liabilities 3,2703,4813,8723,8713,5264,2244,2613,8123,3604,5325,9345,9336,238
Total Liabilities 8,4127,6058,3629,1828,6459,84810,57410,1498,89511,28514,23515,84516,973
Fixed Assets 1,8561,7341,3801,3201,3281,3271,3092,0322,0152,0922,2003,1123,433
CWIP 42074464222481916590141399235162
Investments 160342352477388221201211214243287854943
Other Assets 5,9765,4556,5837,3436,9078,2528,8737,8406,5768,80911,34811,64412,436
Total Assets 8,4127,6058,3629,1828,6459,84810,57410,1498,89511,28514,23515,84516,973

Below is a detailed analysis of the balance sheet data for Coromandel International Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2024, the value is ₹29.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹29.00 Cr..
  • For Reserves, as of Sep 2024, the value is ₹10,126.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹9,390.00 Cr. (Mar 2024) to ₹10,126.00 Cr., marking an increase of 736.00 Cr..
  • For Borrowings, as of Sep 2024, the value is ₹580.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from ₹492.00 Cr. (Mar 2024) to ₹580.00 Cr., marking an increase of 88.00 Cr..
  • For Other Liabilities, as of Sep 2024, the value is ₹6,238.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹5,933.00 Cr. (Mar 2024) to ₹6,238.00 Cr., marking an increase of 305.00 Cr..
  • For Total Liabilities, as of Sep 2024, the value is ₹16,973.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹15,845.00 Cr. (Mar 2024) to ₹16,973.00 Cr., marking an increase of 1,128.00 Cr..
  • For Fixed Assets, as of Sep 2024, the value is ₹3,433.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹3,112.00 Cr. (Mar 2024) to ₹3,433.00 Cr., marking an increase of 321.00 Cr..
  • For CWIP, as of Sep 2024, the value is ₹162.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹235.00 Cr. (Mar 2024) to ₹162.00 Cr., marking a decrease of 73.00 Cr..
  • For Investments, as of Sep 2024, the value is ₹943.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹854.00 Cr. (Mar 2024) to ₹943.00 Cr., marking an increase of 89.00 Cr..
  • For Other Assets, as of Sep 2024, the value is ₹12,436.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹11,644.00 Cr. (Mar 2024) to ₹12,436.00 Cr., marking an increase of 792.00 Cr..
  • For Total Assets, as of Sep 2024, the value is ₹16,973.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹15,845.00 Cr. (Mar 2024) to ₹16,973.00 Cr., marking an increase of 1,128.00 Cr..

Notably, the Reserves (₹10,126.00 Cr.) exceed the Borrowings (580.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

No data available for this post.

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow768.00807.00854.00767.00981.00-1.00-1.00-1.00-384.00-393.00-391.00-490.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days7454475259525048145723
Inventory Days7986969888109127109989469102
Days Payable12913213113515016214713511010083119
Cash Conversion Cycle2471215-3-230222-1-76
Working Capital Days94557710612111612311165413747
ROCE %14%16%19%15%18%23%23%26%32%35%38%26%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Promoters57.53%57.48%57.45%57.41%57.41%57.41%57.34%57.33%57.33%57.32%57.17%56.96%
FIIs7.08%8.04%9.93%10.26%9.40%7.56%7.18%7.71%7.34%7.52%7.79%8.33%
DIIs21.23%20.06%18.65%18.00%18.86%20.59%21.11%20.22%20.63%20.79%21.26%21.01%
Public14.17%14.43%13.97%14.34%14.33%14.46%14.37%14.74%14.70%14.39%13.77%13.68%
No. of Shareholders1,15,4401,39,6671,42,7521,33,7581,32,1031,32,3441,23,6391,26,6281,36,4121,36,4971,41,3491,40,959

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Kotak Emerging Equity Fund - Regular Plan7,423,3112.51850.931,771,4102025-03-10319.06%
DSP Mid Cap Fund5,065,0353.86580.611,771,4102025-03-10185.93%
Axis Midcap Fund4,652,3782.35533.31,771,4102025-03-10162.64%
SBI Magnum Midcap Fund3,778,1823.27433.091,771,4102025-03-10113.29%
Kotak Equity Opportunities Fund - Regular Plan2,450,0001.81280.841,771,4102025-03-1038.31%
Franklin India Prima Fund1,986,2282.59227.681,771,4102025-03-1012.13%
Sundaram Mid Cap Fund1,773,5952.32203.311,771,4102025-03-100.12%
Sundaram Mid Cap Fund - Institutional Plan1,773,5952.32203.311,771,4102025-03-100.12%
SBI Contra Fund1,771,4101.24203.061,771,4102025-03-100%
DSP Equity Opportunities Fund1,298,1341.63148.811,771,4102025-03-10-26.72%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue 1.001.001.001.001.00
Basic EPS (Rs.) 55.8168.5152.0945.3436.40
Diluted EPS (Rs.) 55.8168.3851.9845.2236.31
Cash EPS (Rs.) 64.3975.4957.8351.0241.72
Book Value[Excl.RevalReserv]/Share (Rs.) 320.88268.97216.64175.55147.36
Book Value[Incl.RevalReserv]/Share (Rs.) 320.88268.97216.64175.55147.36
Revenue From Operations / Share (Rs.) 749.271007.75651.14483.37448.35
PBDIT / Share (Rs.) 89.34105.3578.1670.1960.44
PBIT / Share (Rs.) 81.5799.1672.2864.2955.05
PBT / Share (Rs.) 75.2492.7069.7160.6947.02
Net Profit / Share (Rs.) 56.6369.3051.9545.1236.32
NP After MI And SOA / Share (Rs.) 55.7868.4752.0845.3036.35
PBDIT Margin (%) 11.9210.4512.0014.5213.48
PBIT Margin (%) 10.889.8311.1013.3012.27
PBT Margin (%) 10.049.1910.7012.5510.48
Net Profit Margin (%) 7.556.877.979.338.10
NP After MI And SOA Margin (%) 7.446.797.999.378.10
Return on Networth / Equity (%) 17.4325.4524.0325.8024.66
Return on Capital Employeed (%) 24.0434.7931.1133.7133.72
Return On Assets (%) 10.3514.1413.5414.9410.49
Total Debt / Equity (X) 0.010.000.000.000.37
Asset Turnover Ratio (%) 1.472.321.901.481.26
Current Ratio (X) 2.071.751.871.981.45
Quick Ratio (X) 1.280.991.051.190.94
Inventory Turnover Ratio (X) 3.004.843.802.652.53
Dividend Payout Ratio (NP) (%) 10.7517.5123.0339.7011.58
Dividend Payout Ratio (CP) (%) 9.4416.0620.7035.1210.09
Earning Retention Ratio (%) 89.2582.4976.9760.3088.42
Cash Earning Retention Ratio (%) 90.5683.9479.3064.8889.91
Interest Coverage Ratio (X) 14.1016.3030.4019.497.53
Interest Coverage Ratio (Post Tax) (X) 9.9411.7221.2013.535.52
Enterprise Value (Cr.) 28896.1124436.7921701.8121993.0817483.09
EV / Net Operating Revenue (X) 1.310.821.141.551.33
EV / EBITDA (X) 10.997.899.4610.689.87
MarketCap / Net Operating Revenue (X) 1.440.871.231.601.21
Retention Ratios (%) 89.2482.4876.9660.2988.41
Price / BV (X) 3.363.273.694.413.69
Price / Net Operating Revenue (X) 1.440.871.231.601.21
EarningsYield 0.050.070.060.050.06

After reviewing the key financial ratios for Coromandel International Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
  • For Basic EPS (Rs.), as of Mar 24, the value is 55.81. This value is within the healthy range. It has decreased from 68.51 (Mar 23) to 55.81, marking a decrease of 12.70.
  • For Diluted EPS (Rs.), as of Mar 24, the value is 55.81. This value is within the healthy range. It has decreased from 68.38 (Mar 23) to 55.81, marking a decrease of 12.57.
  • For Cash EPS (Rs.), as of Mar 24, the value is 64.39. This value is within the healthy range. It has decreased from 75.49 (Mar 23) to 64.39, marking a decrease of 11.10.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 320.88. It has increased from 268.97 (Mar 23) to 320.88, marking an increase of 51.91.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 320.88. It has increased from 268.97 (Mar 23) to 320.88, marking an increase of 51.91.
  • For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 749.27. It has decreased from 1,007.75 (Mar 23) to 749.27, marking a decrease of 258.48.
  • For PBDIT / Share (Rs.), as of Mar 24, the value is 89.34. This value is within the healthy range. It has decreased from 105.35 (Mar 23) to 89.34, marking a decrease of 16.01.
  • For PBIT / Share (Rs.), as of Mar 24, the value is 81.57. This value is within the healthy range. It has decreased from 99.16 (Mar 23) to 81.57, marking a decrease of 17.59.
  • For PBT / Share (Rs.), as of Mar 24, the value is 75.24. This value is within the healthy range. It has decreased from 92.70 (Mar 23) to 75.24, marking a decrease of 17.46.
  • For Net Profit / Share (Rs.), as of Mar 24, the value is 56.63. This value is within the healthy range. It has decreased from 69.30 (Mar 23) to 56.63, marking a decrease of 12.67.
  • For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 55.78. This value is within the healthy range. It has decreased from 68.47 (Mar 23) to 55.78, marking a decrease of 12.69.
  • For PBDIT Margin (%), as of Mar 24, the value is 11.92. This value is within the healthy range. It has increased from 10.45 (Mar 23) to 11.92, marking an increase of 1.47.
  • For PBIT Margin (%), as of Mar 24, the value is 10.88. This value is within the healthy range. It has increased from 9.83 (Mar 23) to 10.88, marking an increase of 1.05.
  • For PBT Margin (%), as of Mar 24, the value is 10.04. This value is within the healthy range. It has increased from 9.19 (Mar 23) to 10.04, marking an increase of 0.85.
  • For Net Profit Margin (%), as of Mar 24, the value is 7.55. This value is within the healthy range. It has increased from 6.87 (Mar 23) to 7.55, marking an increase of 0.68.
  • For NP After MI And SOA Margin (%), as of Mar 24, the value is 7.44. This value is below the healthy minimum of 8. It has increased from 6.79 (Mar 23) to 7.44, marking an increase of 0.65.
  • For Return on Networth / Equity (%), as of Mar 24, the value is 17.43. This value is within the healthy range. It has decreased from 25.45 (Mar 23) to 17.43, marking a decrease of 8.02.
  • For Return on Capital Employeed (%), as of Mar 24, the value is 24.04. This value is within the healthy range. It has decreased from 34.79 (Mar 23) to 24.04, marking a decrease of 10.75.
  • For Return On Assets (%), as of Mar 24, the value is 10.35. This value is within the healthy range. It has decreased from 14.14 (Mar 23) to 10.35, marking a decrease of 3.79.
  • For Total Debt / Equity (X), as of Mar 24, the value is 0.01. This value is within the healthy range. It has increased from 0.00 (Mar 23) to 0.01, marking an increase of 0.01.
  • For Asset Turnover Ratio (%), as of Mar 24, the value is 1.47. It has decreased from 2.32 (Mar 23) to 1.47, marking a decrease of 0.85.
  • For Current Ratio (X), as of Mar 24, the value is 2.07. This value is within the healthy range. It has increased from 1.75 (Mar 23) to 2.07, marking an increase of 0.32.
  • For Quick Ratio (X), as of Mar 24, the value is 1.28. This value is within the healthy range. It has increased from 0.99 (Mar 23) to 1.28, marking an increase of 0.29.
  • For Inventory Turnover Ratio (X), as of Mar 24, the value is 3.00. This value is below the healthy minimum of 4. It has decreased from 4.84 (Mar 23) to 3.00, marking a decrease of 1.84.
  • For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 10.75. This value is below the healthy minimum of 20. It has decreased from 17.51 (Mar 23) to 10.75, marking a decrease of 6.76.
  • For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 9.44. This value is below the healthy minimum of 20. It has decreased from 16.06 (Mar 23) to 9.44, marking a decrease of 6.62.
  • For Earning Retention Ratio (%), as of Mar 24, the value is 89.25. This value exceeds the healthy maximum of 70. It has increased from 82.49 (Mar 23) to 89.25, marking an increase of 6.76.
  • For Cash Earning Retention Ratio (%), as of Mar 24, the value is 90.56. This value exceeds the healthy maximum of 70. It has increased from 83.94 (Mar 23) to 90.56, marking an increase of 6.62.
  • For Interest Coverage Ratio (X), as of Mar 24, the value is 14.10. This value is within the healthy range. It has decreased from 16.30 (Mar 23) to 14.10, marking a decrease of 2.20.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 9.94. This value is within the healthy range. It has decreased from 11.72 (Mar 23) to 9.94, marking a decrease of 1.78.
  • For Enterprise Value (Cr.), as of Mar 24, the value is 28,896.11. It has increased from 24,436.79 (Mar 23) to 28,896.11, marking an increase of 4,459.32.
  • For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.31. This value is within the healthy range. It has increased from 0.82 (Mar 23) to 1.31, marking an increase of 0.49.
  • For EV / EBITDA (X), as of Mar 24, the value is 10.99. This value is within the healthy range. It has increased from 7.89 (Mar 23) to 10.99, marking an increase of 3.10.
  • For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.44. This value is within the healthy range. It has increased from 0.87 (Mar 23) to 1.44, marking an increase of 0.57.
  • For Retention Ratios (%), as of Mar 24, the value is 89.24. This value exceeds the healthy maximum of 70. It has increased from 82.48 (Mar 23) to 89.24, marking an increase of 6.76.
  • For Price / BV (X), as of Mar 24, the value is 3.36. This value exceeds the healthy maximum of 3. It has increased from 3.27 (Mar 23) to 3.36, marking an increase of 0.09.
  • For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.44. This value is within the healthy range. It has increased from 0.87 (Mar 23) to 1.44, marking an increase of 0.57.
  • For EarningsYield, as of Mar 24, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.07 (Mar 23) to 0.05, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Coromandel International Ltd as of March 12, 2025 is: ₹1,653.99

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 12, 2025, Coromandel International Ltd is Overvalued by 5.81% compared to the current share price 1,756.00

Intrinsic Value of Coromandel International Ltd as of March 12, 2025 is: 1,725.21

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 12, 2025, Coromandel International Ltd is Overvalued by 1.75% compared to the current share price 1,756.00

Last 5 Year EPS CAGR: 4.31%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 23.75%, which is a positive sign.
  2. The company has higher reserves (4,722.23 cr) compared to borrowings (1,686.77 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (15.00 cr) and profit (224.54 cr) over the years.
  1. The stock has a high average Working Capital Days of 82.75, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 8.75, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Coromandel International Ltd:
    1. Net Profit Margin: 7.55%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 24.04% (Industry Average ROCE: 21.99%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 17.43% (Industry Average ROE: 10.62%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 9.94
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 1.28
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 31.6 (Industry average Stock P/E: 41.8)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.01
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Coromandel International Ltd. is a Public Limited Listed company incorporated on 16/10/1961 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24120TG1961PLC000892 and registration number is 000892. Currently Company is involved in the business activities of Manufacture of straight mixed, compound or complex inorganic fertilizers. Company's Total Operating Revenue is Rs. 22029.21 Cr. and Equity Capital is Rs. 29.44 Cr. for the Year ended 31/03/2024.
INDUSTRYADDRESSCONTACT
FertilisersCoromandel House, Secunderabad Telangana 500003investorsgrievance@coromandel.murugappa.com
http://www.coromandel.biz
Management
NamePosition Held
Mr. A VellayanChairman Emeritus
Mr. Arun AlagappanExecutive Vice Chairman
Dr. Raghuram DevarakondaExecutive Director
Mr. S SankarasubramanianExecutive Director
Mr. Arun VellayanWhole Time Director
Mr. Narayanan VellayanWhole Time Director
Mr. Sudarshan VenuIndependent Director
Dr. Deepali Pant JoshiIndependent Director
Mr. Adnan AhmadIndependent Director
Mr. Aditya HimatsingkaIndependent Director
Mr. Suresh SubramanianIndependent Director

FAQ

What is the latest intrinsic value of Coromandel International Ltd?

The latest intrinsic value of Coromandel International Ltd as on 11 March 2025 is ₹1653.99, which is 5.81% lower than the current market price of 1,756.00, indicating the stock is overvalued by 5.81%. The intrinsic value of Coromandel International Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹51,744 Cr. and recorded a high/low of ₹1,978/1,037 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹10,126 Cr and total liabilities of ₹16,973 Cr.

What is the Market Cap of Coromandel International Ltd?

The Market Cap of Coromandel International Ltd is 51,744 Cr..

What is the current Stock Price of Coromandel International Ltd as on 11 March 2025?

The current stock price of Coromandel International Ltd as on 11 March 2025 is ₹1,756.

What is the High / Low of Coromandel International Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Coromandel International Ltd stocks is ₹1,978/1,037.

What is the Stock P/E of Coromandel International Ltd?

The Stock P/E of Coromandel International Ltd is 31.6.

What is the Book Value of Coromandel International Ltd?

The Book Value of Coromandel International Ltd is 345.

What is the Dividend Yield of Coromandel International Ltd?

The Dividend Yield of Coromandel International Ltd is 0.34 %.

What is the ROCE of Coromandel International Ltd?

The ROCE of Coromandel International Ltd is 26.0 %.

What is the ROE of Coromandel International Ltd?

The ROE of Coromandel International Ltd is 18.9 %.

What is the Face Value of Coromandel International Ltd?

The Face Value of Coromandel International Ltd is 1.00.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Coromandel International Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE